Roivant Sciences Ltd.

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	7	-11.8M	100%	$11.61	-$137M
Net	-7	-11.8M	-100%		-$137M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Dexcel Pharma Technologies Ltd.	10%+ Owner	$1.06B			Nov 10, 2022
QVT Financial LP	Director by Deputization	$778M	-$10.9M	-1.39%	Sep 25, 2024
SVF Investments (UK) Ltd	10%+ Owner	$756M			Sep 28, 2023
Sumitomo Chemical Co., Ltd.	10%+ Owner	$737M			Jun 22, 2023
Vivek Ramaswamy	10%+ Owner	$603M			Jan 23, 2025
Daniel Allen Gold	Director	$338M	-$51.8M	-13.3%	Sep 24, 2024
Mayukh Sukhatme	Pres&Chief Investment Officer, Director	$226M	-$15.6M	-6.46%	Dec 23, 2024
Matthew Gline	CEO, Director	$190M	-$23.4M	-11%	Apr 20, 2025
Viking Global Performance Llc	10%+ Owner	$133M			Jun 22, 2023
Viking Global Investors Lp	10%+ Owner	$133M			Jun 22, 2023
Keith Manchester	Director	$15M	-$5.87M	-28.1%	Sep 24, 2024
Eric Venker	President & COO	$12.2M	-$22.5M	-64.9%	Apr 20, 2025
Benjamin Zimmer	President, Roivant Health	$12.1M			Oct 1, 2021
Richard Pulik	Cfo	$2.76M			Mar 28, 2025
Rakhi Kumar	Chief Accounting Officer	$1.74M	-$5.35M	-75.4%	Feb 20, 2025
Jennifer Humes	Chief Accounting Officer	$1.23M			Mar 20, 2025
Ilan Oren	Director	$1.04M			Apr 17, 2025
James C. Momtazee	Director	$971K			Apr 17, 2025
Andrew Lo	Director	$540K			Sep 15, 2022
Melissa B. Epperly	Director	$417K			Apr 17, 2025
Meghan Fitzgerald	Director	$356K			Sep 12, 2024
Hiroshi Nomura	Director				Sep 16, 2022
Masayo Tada	Director				Oct 1, 2021
Patrick Machado	Director				Oct 1, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.